Swiss pharmaceutical giant Roche has announced plans to invest $50 billion in the US over the next five years.
"These investments further strengthen Roche's already significant footprint in the US with 13 manufacturing and 15 research and development sites in the pharmaceuticals and diagnostics divisions and are expected to create more than 12,000 new jobs," the company said in a statement quoted by AFP.
The firm already has plants in the United States and said the move would help expand capacity at sites in Kentucky, Indiana, New Jersey, Oregon and California.
"The investments announced today underscore our long-standing commitment to research, development and manufacturing in the US," said Roche Group CEO Thomas Schinecker.
"Our $50 billion investment over the next five years will lay the foundation for our next era of innovation and growth that will benefit patients in the U.S. and around the world," he added. | BGNES